Elizabeta Nemeth

Elizabeta Nemeth is a Professor of Medicine at the David Geffen School of Medicine, UCLA, and Director of the UCLA Center for Iron Disorders. She specializes in iron metabolism research, focusing on hepcidin and ferroportin roles in health and disease.

• Affiliations: UCLA Clinical and Translational Science Institute, UCLA Digestive Diseases Research Center
• Education: PhD in Cell, Molecular & Neurosciences (University of Hawaii, 1998); BS in Molecular Biology (University of Belgrade, 1993)

Her research explores iron regulation in anemia, pregnancy, and disorders like β-thalassemia. Key contributions include discovering erythroferrone's role in erythropoiesis-driven iron regulation and developing hepcidin-targeted therapies.

Research Interests: Hepcidin biology, iron overload mechanisms, pregnancy iron dynamics, anemia of inflammation, and translational therapeutics. Her work bridges basic science and clinical applications, including diagnostics and drug development.

Awards: William Dameshek Prize (2021), International BioIron Society Presidential Award (2019), Grace Goldsmith Award (2007). Her research has led to three biotech startups focused on iron disorder treatments.

• Grants: NIH-funded projects on iron physiology in pregnancy, erythroferrone's role, and iron's impact on atherosclerosis
• Labs/Teams: Directs UCLA Center for Iron Disorders, collaborates with NIH-funded research networks